Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation

Detalhes bibliográficos
Autor(a) principal: Camm, A. John
Data de Publicação: 2015
Outros Autores: Pinto, Fausto J., Hankey, Graeme J., Andreotti, Felicita, Hobbs, F. D. Richard
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/35323
Resumo: © The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
id RCAP_cb6e1ae854d3f02f76f67f3936348aa9
oai_identifier_str oai:repositorio.ul.pt:10451/35323
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementationAtrial fibrillationGuidelinesOral anticoagulantsStroke prevention© The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comStroke is a leading cause of morbidity and mortality worldwide. Atrial fibrillation (AF) is an independent risk factor for stroke, increasing the risk five-fold. Strokes in patients with AF are more likely than other embolic strokes to be fatal or cause severe disability and are associated with higher healthcare costs, but they are also preventable. Current guidelines recommend that all patients with AF who are at risk of stroke should receive anticoagulation. However, despite this guidance, registry data indicate that anticoagulation is still widely underused. With a focus on the 2012 update of the European Society of Cardiology (ESC) guidelines for the management of AF, the Action for Stroke Prevention alliance writing group have identified key reasons for the suboptimal implementation of the guidelines at a global, regional, and local level, with an emphasis on access restrictions to guideline-recommended therapies. Following identification of these barriers, the group has developed an expert consensus on strategies to augment the implementation of current guidelines, including practical, educational, and access-related measures. The potential impact of healthcare quality measures for stroke prevention on guideline implementation is also explored. By providing practical guidance on how to improve implementation of the ESC guidelines, or region-specific modifications of these guidelines, the aim is to reduce the potentially devastating impact that stroke can have on patients, their families and their carers.Oxford University PressRepositório da Universidade de LisboaCamm, A. JohnPinto, Fausto J.Hankey, Graeme J.Andreotti, FelicitaHobbs, F. D. Richard2018-11-13T16:13:54Z20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/35323engEP Europace, Volume 17, Issue 7, 1 July 2015, Pages 1007–10171532-209210.1093/europace/euv068info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:31:12Zoai:repositorio.ul.pt:10451/35323Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:49:48.185886Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
title Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
spellingShingle Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
Camm, A. John
Atrial fibrillation
Guidelines
Oral anticoagulants
Stroke prevention
title_short Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
title_full Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
title_fullStr Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
title_full_unstemmed Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
title_sort Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice : barriers to and strategies for optimal implementation
author Camm, A. John
author_facet Camm, A. John
Pinto, Fausto J.
Hankey, Graeme J.
Andreotti, Felicita
Hobbs, F. D. Richard
author_role author
author2 Pinto, Fausto J.
Hankey, Graeme J.
Andreotti, Felicita
Hobbs, F. D. Richard
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Camm, A. John
Pinto, Fausto J.
Hankey, Graeme J.
Andreotti, Felicita
Hobbs, F. D. Richard
dc.subject.por.fl_str_mv Atrial fibrillation
Guidelines
Oral anticoagulants
Stroke prevention
topic Atrial fibrillation
Guidelines
Oral anticoagulants
Stroke prevention
description © The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
publishDate 2015
dc.date.none.fl_str_mv 2015
2015-01-01T00:00:00Z
2018-11-13T16:13:54Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/35323
url http://hdl.handle.net/10451/35323
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv EP Europace, Volume 17, Issue 7, 1 July 2015, Pages 1007–1017
1532-2092
10.1093/europace/euv068
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134431608307712